Twenty-seven human embryonic stem cell (hESC) lines are ethically derived and should be approved for use in research funded by the US linkurl:National Institutes of Health;http://www.nih.gov/ (NIH), a committee advising the NIH director linkurl:recommended today (December 4).;http://acd.od.nih.gov/agendas/Tab-1-Agenda-FINAL.pdf These findings come just two days after the approval of the first 13 lines linkurl:earlier this week.;http://www.the-scientist.com/blog/display/56196/
There was one provision, though: The funding must be limited to projects that follow the precise wording in the consent forms, which states the embryos will be used for research on embryonic development of endoderm with a focus on pancreatic beta cell formation. The 27 lines were all part of a single submission from Harvard University, where researchers have been using them for a variety of projects. The Harvard IRB had determined the cells could be used more broadly than stated in the consent forms. A 28th...
 |
Image: Wikimedia commons, Nissim Benvenisty |
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
